Clinical Trial Update: Combination of Haloperidol and Magnesium for Delirium Prevention in Critically Ill Elderly [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 trial evaluating the combination of haloperidol and magnesium for delirium prevention in critically ill elderly patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Delirium in Old Age

Drugs mentioned

• HALOPERIDOL (HALOPERIDOL LACTATE)
• Magnesium (magnesium)

Snippet

Sponsor: Ain Shams University | Conditions: Delirium in Old Age | Phase 2, Phase 3 | Status: COMPLETED